🔗 Permalink

Inventor profile of:

Everett STONE

City:

Austin, Texas

Country:

United States

Published Applications:

Last publication date:

2024-03-21

Top Assignees for applications by Everett STONE

The entities that hold a legal rights for patent applications filed by inventor STONE Everett:

Board of Regents, The University of Texas System 27 Austin, TX United States
AERASE, INC. 7 Austin, TX United States
AEMASE, INC. 5 Austin, TX United States
Antidote Therapeutics, Inc. 1 Sykesville, MD United States
The Board of Regents of the University of Texas System 1 Austin, TX United States
GMA Technologies LLC 1 Austin, TX United States
ANTIDOTE THERAPEUTICS, INC. 1 Bethesda, MD United States
THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 1 AUTIN, TX United States

Recent patent applications by STONE Everett

Everett STONE from Austin, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-03-21

US20240091258A1

Human necessities

ADMINISTRATION OF KYNURENINE DEPLETING ENZYMES FOR TUMOR THERAPY

#2 | 2024-01-11

US20240009283A1

Human necessities

Compositions Of Engineered Human Arginases And Methods For Treating Cancer

#3 | 2023-12-28

US20230416697A1

Chemistry; metallurgy

NOVEL NICOTINE DEGRADING ENZYME VARIANTS

#4 | 2023-12-21

US20230405049A1

Human necessities

Human Kynureninase enzymes and uses thereof

#5 | 2023-07-20

US20230227796A1

Chemistry; metallurgy

ENZYME-MEDIATED DEPLETION OF ADENOSINE AND/OR METHYLTHIOADENOSINE

#6 | 2022-09-01

US20220275099A1

Chemistry; metallurgy

ADMINISTRATION OF KYNURENINE DEPLETING ENZYMES FOR TUMOR THERAPY

#7 | 2022-02-17

US20220047683A1

Human necessities

Human methylthioadenosine/adenosine depleting enzyme variants for cancer therapy

#8 | 2022-02-10

US20220042001A1

Chemistry; metallurgy

Human methylthioadenosine/adenosine depleting enzyme variants for cancer therapy

#9 | 2021-12-16

US20210386838A1

Human necessities

Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocysteinemia and homocystinuria

#10 | 2021-12-09

US20210380962A1

Chemistry; metallurgy

Engineered primate cystine/cysteine degrading enzymes for therapeutic uses

#11 | 2021-07-15

US20210213059A1

Human necessities

Nucleic acids encoding kynurenine depleting enzymes

#12 | 2021-07-08

US20210207110A1

Chemistry; metallurgy

Human kynureninase enzyme variants having improved pharmacological properties

#13 | 2021-05-06

US20210128703A1

Human necessities

Compositions Of Engineered Human Arginases And Methods For Treating Cancer

#14 | 2021-04-01

US20210095264A1

Chemistry; metallurgy

Enzyme-mediated depletion of adenosine and/or methylthioadenosine

#15 | 2021-02-25

US20210054350A1

Chemistry; metallurgy

ENZYME-MEDIATED DEPLETION OF ADENOSINE AND/OR METHYLTHIOADENOSINE

#16 | 2020-10-29

US20200338197A1

Human necessities

Engineered primate cystine/cysteine degrading enzymes as antineogenic agents

#17 | 2020-07-16

US20200224176A1

Chemistry; metallurgy

Nicotine degrading enzyme variants

#18 | 2020-03-19

US20200087706A1

Chemistry; metallurgy

Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereof

#19 | 2020-02-20

US20200054674A1

Human necessities

Administration of kynurenine depleting enzymes for tumor therapy

#20 | 2020-02-06

US20200038511A1

Human necessities

Engineered primate cystine/cysteine degrading enzymes as antineogenic agents

#21 | 2019-12-26

US20190390187A1

Chemistry; metallurgy

Engineered primate L-methioninase for therapeutic purposes

#22 | 2019-11-21

US20190350975A1

Human necessities

Human kynureninase enzymes and uses thereof

#23 | 2019-01-03

US20190002579A1

Chemistry; metallurgy

Administration of kynurenine depleting enzymes for tumor therapy

#24 | 2019-01-03

US20190000939A1

Human necessities

COMPOSITIONS OF ENGINEERED HUMAN ARGINASES AND METHODS FOR TREATING CANCER

#25 | 2018-11-15

US20180327734A1

Chemistry; metallurgy

Engineered primate cystine/cysteine degrading enzymes for therapeutic uses

#26 | 2018-11-15

US20180326025A1

Human necessities

Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocysteinemia and homocystinuria

#27 | 2018-06-21

US20180171380A1

Chemistry; metallurgy

Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereof

#28 | 2018-01-11

US20180008681A1

Human necessities

HUMAN-ENZYME MEDIATED DEPLETION OF CYSTINE FOR TREATING PATIENTS WITH CYSTINURIA

#29 | 2018-01-04

US20180002685A1

Chemistry; metallurgy

Engineered primate L-methioninase for therapeutic purposes

#30 | 2017-05-11

US20170128553A1

Human necessities

Compositions of engineered human arginases and methods for treating cancer

#31 | 2017-03-02

US20170056449A1

Human necessities

ADMINISTRATION OF KYNURENINE DEPLETING ENZYMES FOR TUMOR THERAPY

#32 | 2017-02-16

US20170044514A1

Chemistry; metallurgy

Engineered primate L-methioninase for therapeutic purposes

#33 | 2016-06-16

US20160168620A1

Chemistry; metallurgy

Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereof

#34 | 2016-03-03

US20160058845A1

Human necessities

Administration of kynurenine depleting enzymes for tumor therapy

#35 | 2015-03-05

US20150064160A1

Human necessities

Engineered primate cystine/cysteine degrading enzymes as antineogenic agents

#36 | 2015-03-05

US20150064159A1

Chemistry; metallurgy

Engineered primate L-methioninase for therapeutic purposes

#37 | 2015-03-05

US20150064154A1

Chemistry; metallurgy

Administration of kynurenine depleting enzymes for tumor therapy

#38 | 2014-09-25

US20140287484A1

Chemistry; metallurgy

Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereof

#39 | 2014-08-28

US20140242060A1

Chemistry; metallurgy

COMPOSITIONS OF ENGINEERED HUMAN ARGINASES AND METHODS FOR TREATING CANCER

#40 | 2013-10-17

US20130273022A1

Human necessities

Compositions of engineered human arginases and methods for treating cancer

#41 | 2012-07-12

US20120177628A1

Chemistry; metallurgy

Methods for purifying pegylated arginase

#42 | 2011-08-18

US20110200576A1

Chemistry; metallurgy

Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereof

#43 | 2010-05-06

US20100111925A1

Human necessities

Compositions of engineered human arginases and methods for treating cancer

#44 | 2009-09-24

US20090238813A1

Human necessities

Compositions And Methods For Engineered Human Arginine Deiminases

InventorID:

486160 ⎘